Patents by Inventor Mathias Falcenberg

Mathias Falcenberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treatment of diabetes by a small molecule inhibitor for GRK5
    Patent number: 9458463
    Abstract: The present invention is related to compound capable of modulating the activity and/or expression of the protein kinase GRK5, thereby enhancing the expression and/or release of insulin. The invention is further related to methods of identifying said compounds for the treatment of diseases of the carbohydrate metabolism. The invention is further related to methods of treatment of diseases of the carbohydrate metabolism, particularly diabetes mellitus type 2.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: October 4, 2016
    Assignee: MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
    Inventors: Mathias Falcenberg, Axel Ullrich
  • KINASES AS TARGETS FOR ANTI-DIABETIC THERAPY
    Publication number: 20150079108
    Abstract: The present invention is related to compound capable of modulating the activity and/or expression of the protein kinase GRK5, thereby enhancing the expression and/or release of insulin. The invention is further related to methods of identifying said compounds for the treatment of diseases of the carbohydrate metabolism. The invention is further related to methods of treatment of diseases of the carbohydrate metabolism, particularly diabetes mellitus type 2.
    Type: Application
    Filed: November 26, 2014
    Publication date: March 19, 2015
    Inventors: Mathias Falcenberg, Axel Ullrich
  • KINASES AS TARGETS FOR ANTI-DIABETIC THERAPY
    Publication number: 20130336986
    Abstract: The present invention is related to compound capable of modulating the activity and/or expression of the protein kinases SCYL1, ADCK1, and GRK5, thereby enhancing the expression and/or release of insulin. The invention is further related to methods of identifying said compounds for the treatment of diseases of the carbohydrate metabolism. The invention is further related to methods of treatment of diseases of the carbohydrate metabolism, particularly diabetes mellitus type 2.
    Type: Application
    Filed: September 5, 2011
    Publication date: December 19, 2013
    Applicant: MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
    Inventors: Mathias Falcenberg, Axel Ullrich